PNO1

Across TCGA pan-cancer cohorts, PNO1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PNO1 data layer compared with 25 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher PNO1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PNO1 expression acts as an unfavorable survival marker.

READ and CESC are the cancer types where PNO1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	II,III,IV	0.187	0.644	.023	12	view →
CESC	OS	Median	All	0.258	0.798	.005	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

PNO1–READ (OS)

Open the READ breakdown →